Aseptic Meningitis Following the Second Dose of Comirnaty Vaccination in an Adolescent Patient: A Case Report

Pediatr Infect Dis J. 2022 Feb 1;41(2):172-174. doi: 10.1097/INF.0000000000003385.


Vaccination is currently the best strategy to control the coronavirus disease 2019 epidemic. This report describes a case of aseptic meningitis 3 weeks after administration of the second dose of Comirnaty. The patient recovered with conservative and symptomatic care after 5 days of admission. Surveillance of rare adverse events, including aseptic meningitis, and their management should be prompt and appropriate.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • BNT162 Vaccine / adverse effects*
  • COVID-19 Drug Treatment
  • Humans
  • Male
  • Meningitis, Aseptic / etiology*
  • Meningitis, Aseptic / therapy
  • SARS-CoV-2
  • Treatment Outcome


  • BNT162 Vaccine